NO GO: The Food and Drug Administration won't OK Merck's new combo cholesterol drug without more data. Merck says new data on compound MK-0653C, expected later this year, may address FDA questions.
LIPITOR LURE?: The experimental drug combines Merck cholesterol pill Zetia with generic Lipitor, which had been the top-selling drug ever but got generic competition three months ago.
NEW AND IMPROVED: Merck already sells Vytorin, a cholesterol pill that combines Zetia with generic Zocor, a Merck drug similar to but not as strong as Lipitor. The new combo might work better than Vytorin.
An Unserious Candidate for an Unserious Country | RedState
The Koran’s Contents—Not Carbon Dating—Cast More Doubt on Islam’s Origins | Human Events
CNN: Aide's Fifth Amendment declaration sure makes the Hillary server fiasco look criminal, huh?
Guy Benson - Top Senate Foreign Relations Committee Democrat Opposes Obama's Iran Deal
'Gut wrenching': Deputy Goforth's son wears superhero shirt to funeral he planned to wear with his dad
Concealed Carrier Shoots Armed Robber In Detroit... Again. Still. - Bearing Arms - Detroit, Guns Saving Lives, Michigan
Lawrence Meyers - Uber’s Death by A Thousand Cuts